Targeting BRIX1 via Engineered Exosomes Induces Nucleolar Stress to Suppress Cancer Progression
2024

Targeting BRIX1 to Fight Cancer

publication 10 minutes Evidence: high

Author Information

Author(s): Gan Yu, Hao Qian, Han Tao, Tong Jing, Yan Qingya, Zhong Hongguang, Gao Bo, Li Yanan, Xuan Zhisheng, Li Pengfei, Yao Litong, Xu Yingying, Jiang Yi‐Zhou, Shao Zhi‐Ming, Deng Jun, Chen Jiaxiang, Zhou Xiang

Primary Institution: Fudan University Shanghai Cancer Center

Hypothesis

Can targeting the nucleolar protein BRIX1 suppress cancer progression?

Conclusion

Targeting BRIX1 via engineered exosomes can effectively suppress colorectal cancer and enhance chemotherapy efficacy.

Supporting Evidence

  • BRIX1 is a critical regulator of ribosome biogenesis and p53 activation.
  • Depletion of BRIX1 induces nucleolar stress and activates p53, inhibiting tumor growth.
  • Engineered exosomes loaded with siRNAs against BRIX1 significantly suppressed colorectal cancer growth.
  • High levels of BRIX1 correlate with poor prognoses in breast and colorectal cancers.

Takeaway

Scientists found that a protein called BRIX1 helps cancer cells grow. By using special exosomes to deliver a treatment that targets BRIX1, they can slow down cancer growth.

Methodology

The study used bioinformatics analysis, cell-based assays, and engineered exosomes to investigate the role of BRIX1 in cancer.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1002/advs.202407370

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication